APOTEA: Q2 saw 10.9% revenue growth, strong Rx performance, and a 5.2% adjusted EBIT margin
Q2 delivered strong profitability and 10.9% revenue growth, driven by Rx segment expansion and the launch of apotea.no in Norway. Adjusted EBIT margin reached 5.2%, with continued focus on growth initiatives and operational efficiency.Based on Apotea AB [APOTEA] Q2 2026 Audio Transcript — Jul. 17 2…